You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

 

Online download statistics by month:

Online download statistics by month: March 2022 to August 2025

AbstractFullPdf
Mar 2022915949518
Apr 2022362376174
May 2022274282246
Jun 2022249253172
Jul 2022221225124
Aug 202223223497
Sep 2022303315199
Oct 2022336342197
Nov 2022372377143
Dec 2022205205104
Jan 2023177179107
Feb 2023202202124
Mar 2023243245114
Apr 202317217798
May 202317517790
Jun 2023168169143
Jul 2023184188148
Aug 2023183185130
Sep 2023182183109
Oct 2023162162132
Nov 2023184183146
Dec 2023202203165
Jan 2024192193164
Feb 202415215691
Mar 2024200204206
Apr 2024181185141
May 2024165167113
Jun 2024180184272
Jul 2024178180117
Aug 2024101100140
Sep 2024137138965
Oct 2024142143145
Nov 2024155156134
Dec 2024246254141
Jan 2025156159104
Feb 2025215216166
Mar 2025201202158
Apr 2025216219153
May 2025178180128
Jun 2025141145105
Jul 2025110
Aug 2025110
Total884189946923